Indefinite Delivery Contract HHSN271201600007I
- The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite delivery/indefinite quantity contract to IIT Research Institute of Chicago, Illinois with a potential value of $174,470,000. The contract aims to procure pharmacology and toxicology services to support the Pharmacology and Toxicology for Therapeutics Program. Services include non-GLP ADME/PK/TOX studies for up to 10 projects annually, GLP enabling toxicology studies for up to 5...
- Southern Research Institute, a non-profit biomedical research organization based in Birmingham, Alabama, was awarded a single-award Indefinite Delivery Contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 15, 2025, with a ceiling value of $50,000,000 and an ultimate completion date of September 14, 2032. The contract procures Interventional Agents Safety and Pharmacokinetic Services, encompassing specialized scientific research and development activities...
- Southern Research Institute, a non-profit research organization based in Birmingham, Alabama, was awarded a single-award Indefinite Delivery Contract by the National Institute of Allergy and Infectious Diseases (NIAID) with a ceiling value of $255.8 million. The contract was awarded on September 15, 2003, with an ultimate completion date of December 11, 2015. The contract supports research and development in the physical, engineering, and life sciences, with all work performed at Southern...
- This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...
- The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery/indefinite-quantity contract to the University of Illinois with a potential value of $174.47 million. The contract supports the Pharmacology and Toxicology for Therapeutics Program, which aims to advance promising new treatments through preclinical testing. Under the contract, the University of Illinois will provide management and operations support services, as well as...
- The National Institute of Allergy and Infectious Diseases awarded a $30 million Indefinite Delivery/Indefinite Quantity multiple-award contract to Southern Research Institute on January 11, 2019, with an ultimate completion date of January 14, 2026. This Indefinite Delivery contract, titled "In Vitro Assessments of Antimicrobial Activity" (IVAAA), was issued without set-aside designation and establishes a master contract vehicle for Southern Research to provide specialized...
- The federal contract IDV award is for safety evaluation and toxicology studies and related services to support drug development efforts of the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The prime contractor, SRI International, a nonprofit research and development institute, will provide in vitro and in vivo exploratory and Investigational New Drug (IND)-directed toxicology studies for small molecule and biologic...
- This indefinite delivery contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development institute. The $9.75 million IDC has a period of performance from September 12, 2023 to September 11, 2028 and is for toxicological evaluations of potential medications to support NIDA's mission. Under this IDC, Sri International has been awarded two task orders so far....
- This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit organization. The contract, valued at up to $24,293,824, is for an "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" and does not have a set-aside designation. Under this IDC, Southern Research Institute is providing a range of services, including optimization and...
- This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The contract has a ceiling value of $136,588,701.00 and a period of performance from September 30, 2025 to September 29, 2035. The purpose of this contract is to provide "EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR...
- HHSN271201600007IIndefinite Delivery Contract
- 3Federal Contract Awards
This Indefinite Delivery Contract is a parent IDIQ vehicle awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ has a total potential value of $174,470,000 and a period of performance through September 12, 2026. Under this IDIQ, Southern Research has been awarded multiple task orders to provide drug discovery, development, and testing services. The task orders summarized include a $639,445 cost-plus-fixed-fee contract for pharmacokinetics and toxicology studies on a drug candidate, a $907,798 cost-plus-fixed-fee task order for continuous rodent and non-rodent pharmacokinetic assessments, and a $414,199 firm-fixed-price task order for management and operations support. The work under these task orders will be performed in Bethesda, Maryland and Birmingham, Alabama. Southern Research has a history of providing advanced research services, including drug discovery, medicinal chemistry, and toxicology evaluations, to various federal agencies like the NIH, CDC, and Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Other Administrative Action | $0 | 5/3/24 | |
| P00007 | Other Administrative Action | $0 | 6/23/22 | |
| P00006 | Supplemental Agreement for work within scope | $0 | 10/15/21 | |
| P00005 | Other Administrative Action | $0 | 11/6/19 | |
| P00004 | Change Order | $0 | 8/21/19 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HHSN271201600007I-HHSN27100001 | Southern Research Institute | $414.2k | 9/13/16 | 9/12/20 | 8/7/19 | |
Delivery Order HHSN271201600007I-75N95018F00003 | Southern Research Institute | $619.5k | 9/26/18 | 12/26/20 | 11/22/24 | |
Delivery Order HHSN271201600007I-HHSN27100002 | Southern Research Institute | $809.6k | 9/22/17 | 9/29/20 | 5/23/24 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmacology and Toxicology for Therapeutics Program (PTTP) | NIH-NINDS-16-01 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 3/4/16, 3:43 PM |